In August, UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Sunlenca (lenacapavir) injection and tablets, alongside other antiretrovirals, in adu 21 October 2022
Boston, Massachusetts-based nonprofit The Institute for Clinical and Economic Review (ICER) has issued its final report into the cost-effectiveness of the lates 21 October 2022
Drugmakers in Europe are arguing for a new economic model for reimbursement of antibiotics, paving the way for a breakthrough in the fight against antimicrobial 28 September 2022
Drug pricing policy changes in the USA were signed into law as part of the Inflation Reduction Act last month in one of the most impactful acts of the Biden adm 21 September 2022
The Initiative for Medicines, Access, and Knowledge (I-MAK), a campaign group seeking to drive down the cost of medicines, has taken aim at pharma firms’ protec 16 September 2022
Sophisticated products in the form of biologics and large molecules, produced by living materials from humans, animals, plants, or microorganisms, are increasin 13 September 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.